Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
A new seminal review in a special issue of the Journal of Dairy Science® highlights that the complex structure of dairy foods affects their metabolism beyond just their composition David W. Everett, ...
Introduction: Residential load forecasting is a challenging task due to the random fluctuations caused by complex correlations and individual differences. The existing short-term load forecasting ...
Shares of Structure Therapeutics jumped more than 45% Monday after a new clinical study boosted prospects the biotech can claim a piece of the growing anti-obesity drug market with a pill—an eagerly ...
MIAMI--(BUSINESS WIRE)--The Data Science and Machine Learning (DSML) platform market has continued to expand as data volumes surge exponentially across industries and organizations increasingly rely ...
Driven by high technologies such as big data, a revolution has taken place in the field of life sciences and a paradigm shift. The paradigm of science determines the organizational model of science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results